PCNA: A Constitutive Human Promoter for Gene Expression for Functional Studies and Therapeutic Applications


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

We have cloned the promoter of the human PCNA gene that codes for a proliferating cell-nuclear antigen. Two promoter DNA fragments were cloned of 1416 and 389 bp in length. Expression of luc and PDX1 genes under the control of the PCNA promoter was demonstrated in transient and stable transfection in human and mouse cell lines. We have shown that PCNA promoter within genetically engineered vectors is able to promote efficient expression of heterologous genes at a level comparable to a widely used CMV promoter. In particular, we report a comparative analysis of expression of PDX1, a master regulator gene in the pancreas, under PCNA promoter in pancreatic cancer cells. We propose that PCNA promoter can be used as a universal one in the design of therapeutic gene constructs.

Sobre autores

L. Kondratyeva

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Autor responsável pela correspondência
Email: liakondratyeva@yandex.ru
Rússia, Moscow, 117997

K. Kashkin

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: liakondratyeva@yandex.ru
Rússia, Moscow, 117997

I. Chernov

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: liakondratyeva@yandex.ru
Rússia, Moscow, 117997

E. Stukacheva

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: liakondratyeva@yandex.ru
Rússia, Moscow, 117997

D. Dydich

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: liakondratyeva@yandex.ru
Rússia, Moscow, 117997

E. Kopantzev

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: liakondratyeva@yandex.ru
Rússia, Moscow, 117997

E. Sverdlov

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: liakondratyeva@yandex.ru
Rússia, Moscow, 117997

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Allerton Press, Inc., 2017